Innovation Pharmaceuticals Inc (IPIX)

[TheDane]

I’m reading this NPR article and am amazed. Why was this information released with the study only half done and with these caveats?

https://www.npr.org/sections/health-shots/2020/04/29/848034963/antiviral-drug-remdesivir-shows-promise-for-treating-coronavirus-in-nih-study

“ First, he underlined that this is preliminary data, based on about half the patients in the trial, and it "has not undergone the robust analysis that will be conducted by the statisticians and the scientists at the NIH in the coming weeks."

And while the preliminary data showed no serious side effects of remdesivir, "we still don't have all the safety data reported from the NIH, and that will be critically important to understanding how we use this medicine in the future," he said.

Mehta also noted that remdesivir isn't a cure-all.”

BrilAcidin to the rescue!